Vaccination of mice with either Formalin-killed cells or cell extracts of a virulent strain and a weakly virulent strain of Vibrio vulnificus or with rabbit antisera (AS) against the Formalin-killed cells and cell extracts protected against the virulent strain of V. vulnificus. However, the virulent strain vaccines and AS elicited a significantly stronger immune response than the weakly virulent strain vaccines and AS. Adsorption of the AS with either the homologous or heterologous Formalin-killed cells significantly reduced the ability of the AS to protect mice. The major protective antigen(s) in the cell extracts migrated in the void volume of Sephacryl S-400 superfine, was not effectively sedimented by centrifugation at 100,000 x g for 2 h, had an isoelectric point of 3.8 to 4.2, and was sensitive to boiling or autoclaving for 15 min, periodate oxidation, and exposure to pH 12 but was resistant to 56°C, trypsin, pronase, RNase, neuraminidase, and pH 4.5. Electron microscopy revealed that the virluent strain possessed a more dense ruthenium red-staining layer on its outer membrane and had a much smoother surface than the weakly virulent strain. Our results provide evidence that a major protective antigen and virulence factor of V. vulnificus is a heat-labile, acidic polysaccharide located on the bacterial surface.
vulnificus and seed culture suspensions were prepared as previously described (18) , except the seed cultures were grown on Columbia agar (BBL Microbiology Systems, Cockeysville, Md.) rather than on Columbia agar containing 5% sheep blood. Flask cultures were prepared by inoculating 2-liter flasks containing 200 ml of heart infusion broth (Difco Laboratories, Detroit, Mich.) with 1 ml of seed culture suspension (ca. 1010 CFU) and incubating the inoculated medium for 7 to 8 h at 30°C on a gyratory shaker operating at 220 cycles per min.
Killed cell vaccines. The bacteria obtained from one flask culture, or from several Columbia agar cultures grown as described for electron microscopy studies, were collected by centrifugation (10,000 x g, 15 min, 4C), washed twice with sterile phosphate-buffered saline (PBS; 0.02 M Na2HPO4-HCl-0.15 M NaCl [pH 7.4]), and suspended in 50 ml of PBS. The number of CFU per ml of suspension (usually ca. 5 x 1010 CFU/ml) was determined by plate counts, and the bacteria in 10-ml portions of the suspension were killed by exposure to (i) 0.8% (vol/vol) Formalin for 1 day at ca. 25°C, (ii) 56°C for 15 min, (iii) 100°C for 15 min, and (iv) autoclaving (121°C) for 15 min. The heat-treated suspensions were cooled to room temperature, adjusted to contain 0.8% Formalin, and kept for 1 day at ca. 25°C. The vaccines were stored at 4°C, and 1-ml portions were diluted with sterile PBS, before being used in the active immunization studies, to mixing the washed bacteria in the blender indicated that the treatment did not cause detectable loss of bacterial viability. The virulent strain cell extract (CE) was further fractionated, in some experiments, into an insoluble or sedimentable fraction and a soluble or nonsedimentable fraction by centrifugation at 100,000 x g for 2 h.
Antisera. Rabbit antisera (AS) against Formalin-killed cells (FKC) of V. vulnificus E4125 and A1402 were obtained as previously described (17) . AS had agglutination titers of 500 to 1,000 when tested against the homologous and heterologous FKC by a tube agglutination procedure (11) . AS against the CEs of the two strains were obtained by vaccinating New Zealand white rabbits s.c. on day 0 with 1.2 ml of an emulsion composed of equal parts of CE and Freund complete adjuvant and on day 28 with 1.2 ml of an emulsion composed of CE and Freund incomplete adjuvant. The rabbits were exsanguinated 2 weeks after the second vaccination, and AS were lyophilized. AS had agglutination titers of 1,000 to 2,000 against the homologous and heterologous FKC. In some experiments, 5-ml samples of heat-inactivated AS were adsorbed twice with the homologous or heterologous FKC as previously described (17) .
Assays. The assay for protective antigen (PA) activity was performed by determining the ability of the preparations to actively immunize 6-to 8-week-old (ca. 25-to 30-g), Dub:(ICR) strain, randomly bred albino mice against fatal V. vulnificus disease. Groups of mice (10 mice per group) were injected intraperitoneally on days 0, 3, 6, and 9 with 0.2-ml portions of the preparations being examined, and the mice were challenged s.c. on day 16 with 100 or 10 LD50s of V. vulnificus E4125. The percent survival values were determined after observing the animals for 3 days postinfection. The ability of the rabbit AS to passively immunize mice against fatal V. vulnificus disease was determined by intraperitoneal injection of heat-inactivated sera (0.5 ml) into groups of mice (10 mice per group) 3 to 4 h before challenge with 100 or 10 LD50s of V. vulnificus E4125. The bacterial suspensions used to challenge the mice in the active and passive immunization studies were prepared by growing the bacteria in heart infusion broth (as described for the preparation of the vaccines), washing the bacteria with PBS, and suspending the bacteria to yield the required LD50s in 0. (1) 100 ( Table 2 ) and CEs (data not shown). First, the AS passively protected mice against fatal disease caused by s.c. challenge with V. vulnifiuius; however, the AS raised against the virulent strain vaccines protected significantly better than did the AS raised against the weakly virulent strain vaccines. This observation supports the idea that the immunity elicited by the vaccines is humoral or antibody mediated rather than cell mediated and confirms the results obtained during the active immunization experiments, which indicated a quantitative or qualitative difference in the PAs possessed by the virulent and weakly virulent bacteria.
Second, the observation that adsorption of the AS with the homologous FKC markedly reduced the ability of the AS to protect mice confirmed our suspicion that the PA is located on the bacterial surface. We suspected, before performing the adsorption studies, that the PA was located on or loosely attached to the bacterial surface because of our previous observation that CEs containing the antigen could be obtained from V. l'ulnificuis by a procedure which did not cause detectable cell lysis or loss of viability.
Third, despite the previous observation that weakly virulent strain FKC elicited a significantly weaker immune response than did virulent strain FKC (Table 1) , adsorption of the virulent strain AS with the weakly virulent strain FKC was as effective in reducing the protective activity of the AS as was adsorption of the AS with the virulent strain FKC. Incubation of the weakly virulent strain FKC with normal rabbit serum before adsorbing the AS with the FKC did not reduce the protective antibody-adsorbing ability of the cells (Table 2) . Thus, the ability of the FKC to adsorb the protective antibodies does not appear to be caused by antiserum.
' Samples (5 ml) of heat-inactivated normal rabbit serum (NRS) were adsorbed with the FKC as previously described for the adsorption of AS (17) .
and the cells then were used to adsorb the antiserum. vulnificus strains.
Experiments were not performed to determine the mechanism(s) for the strong passive immunity conferred by the antibodies raised against the virulent V. wulnificius strain.
One possible mechanism is that the antibodies enhanced in vivo phagocytosis and clearance of V. vu/nificus. The virulent V. vulnificus strain used in our studies is resistant to in vitro phagocytosis, whereas the weakly virulent strain is readily phagocytized in vitro by human polymorphonuclear leukocytes (17) . In addition, AS raised against FKC of the virulent strain significantly enhances both the amount and rate of phagocytosis of V. vulnificus (17 100 ,ug/ml) were done at 37'C for 2 h. The pH 12 and 4.5 preparations were adjusted to pH 6 to 8 before injection into mice. All of the treated preparations were diluted with an equal volume of PBS before being assayed for PA activity.
h The P values for the comparison of the treated CEs with the control CEs are within parentheses. The 95% significance level for the CEs subjected to periodate oxidation is P = 0.05. Because of multiple-comparison corrections. the 95% significance level for the other treated CEs is P = 0.0125.
As described by Spiro (30 (Fig. 3) . Our physicochemical data support the idea that the PA is an acidic polysaccharide, and ruthenium red is thought to be a specific stain for acidic polysaccharides; however, further studies are needed to determine whether the ruthenium red-staining substance(s) on the bacterial surface is the PA described in our communication. Recently, in vitro passage of Baciteroides fragilis 23745 has been reported to select for a small colony type variant which has reduced virulence and significantly less ruthenium red-staining capsular polysaccharide and is significantly more sensitive to complement-dependent phagocytosis than are the parental, large colony type cells (15, 27) .
In conclusion, our current hypothesis to explain the data in this communication, the results obtained during our previous phagocytosis studies (17) , and the data of Carruthers and Kabat (6) ) is that V. vulnificus virulence is associated with the possession of a heat-labile, acidic polysaccharide surface component that has PA activity and aids the bacterium in resisting in vivo phagocytosis or complement-mediated lysis or both. Studies are in progress to obtain highly purified preparations of the PA so that we can subject our hypothesis to further experimental evaluation.
